The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome

Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus

(2016) Hiddo J.L. Heerspink et al.   CIRCULATION

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

(2016) Christoph Wanner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

(2015) J. P. Schanstra et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Proteomic biomarkers in kidney disease: issues in development and implementation

(2015) Harald Mischak et al.   Nature Reviews Nephrology

Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study

(2014) Sandra Silva et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

(2013) David Z.I. Cherney et al.   CIRCULATION

Comparison of CE-MS/MS and LC-MS/MS sequencing demonstrates significant complementarity in natural peptide identification in human urine

(2013) Julie Klein et al.   ELECTROPHORESIS

Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications

(2013) Angelique Stalmach et al.   ELECTROPHORESIS

Chronic kidney disease: global dimension and perspectives

(2013) Vivekanand Jha et al.   LANCET

Technical aspects and inter-laboratory variability in native peptide profiling: The CE–MS experience

(2012) Harald Mischak et al.   CLINICAL BIOCHEMISTRY

Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers

(2011) Mohammed Dakna et al.   BMC BIOINFORMATICS

Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis

(2010) Tim O. Lankisch et al.   HEPATOLOGY

Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

(2010) David M. Good et al.   MOLECULAR & CELLULAR PROTEOMICS

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

(2010) Sten Andersen et al.   BMC Nephrology

Urinary Proteome Analysis using Capillary Electrophoresis Coupled to Mass Spectrometry: A Powerful Tool in Clinical Diagnosis, Prognosis and Therapy Evaluation

(2009) Harald Mischak et al.   Journal of Medical Biochemistry

Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

(2009) Marion Haubitz et al.   MOLECULAR & CELLULAR PROTEOMICS

Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease

(2008) Justyna Jantos-Siwy et al.   JOURNAL OF PROTEOME RESEARCH